Related content

Indication of Bevacizumab for Cerebral Radiation Necrosis

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 12, Iss. 3, 2017-09 ,pp. : 272-277

Bentham Science Publishers

Access to resources Recommend Favorite

Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis of 579 patients treated with epirubicin-based chemotherapy

By Ryberg Marianne  

Breast Cancer Research and Treatment, Vol. 91, Iss. 3, 2005-06 ,pp. : 217-225

Springer Publishing Company

Access to resources Recommend Favorite

Secondary Analysis of Radiation Therapy Oncology Group study (RTOG) 9310: An Intergroup Phase II Combined Modality Treatment of Primary Central Nervous System Lymphoma

By Fisher Barbara   Seiferheld Wendy   Schultz Christopher   DeAngelis Lisa   Nelson Diane   Schold S.   Curran W.   Mehta M.  

Journal of Neuro-Oncology, Vol. 74, Iss. 2, 2005-09 ,pp. : 201-205

Springer Publishing Company

Access to resources Recommend Favorite

Bevacizumab Treatment for Symptomatic Radiation Necrosis Diagnosed by Amino Acid PET

By Furuse Motomasa   Nonoguchi Naosuke   Kawabata Shinji   Yoritsune Erina   Takahashi Masatsugu   Inomata Taisuke   Kuroiwa Toshihiko   Miyatake Shin-Ichi  

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 3, 2013-03 ,pp. : 337-341

Oxford University Press

Access to resources Recommend Favorite

Immunohistological profiling by B-cell differentiation status of primary central nervous system lymphoma treated by high-dose methotrexate chemotherapy

By Kinoshita Manabu   Hashimoto Naoya   Izumoto Shuichi   Okita Yoshiko   Kagawa Naoki   Maruno Motohiko   Ohnishi Takanori   Arita Norio   Yoshimine Toshiki  

Journal of Neuro-Oncology, Vol. 99, Iss. 1, 2010-08 ,pp. : 95-101

Springer Publishing Company

Access to resources Recommend Favorite